Financhill
Back

NLS Pharmaceutics Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
28

NLSP
NLS Pharmaceutics

Last Price:
$2.32
Seasonality Move:
-28.8%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
28
NLS Pharmaceutics (NLSP) is a Sell

Is NLS Pharmaceutics a Buy, Sell or Hold?

  • The current NLS Pharmaceutics [NLSP] share price is $2.32. The Score for NLSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NLSP Stock Price Chart

What is NLS Pharmaceutics's stock price today?

  • The NLS Pharmaceutics share price today is $2.32
    The current trend is relatively stagnant and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

NLSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 48.94 Sell
Chaikin Money Flow: 255458 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.86 - 2.34) Buy
Bollinger Bands (100): (2.61 - 5.67) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

NLSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.26 Buy
20-day SMA: 2.07 Buy
50-day SMA: 2.85 Sell
200-day SMA: 5.44 Sell
8-day EMA: 2.21 Buy
20-day EMA: 2.25 Buy
50-day EMA: 2.89 Sell
200-day EMA: 7.4 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

NLS Pharmaceutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):